Cell Source, Inc. (CLCS)
OTCMKTS · Delayed Price · Currency is USD
0.8908
+0.0163 (1.86%)
At close: Jul 7, 2026
Cell Source Market Cap
Cell Source has a market cap or net worth of $60.53 million as of July 7, 2026. Its market cap has increased by 282.94% in one year.
Market Cap
60.53M
Enterprise Value
71.34M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.89
Market Cap Chart
Since July 1, 2014, Cell Source's market cap has increased from 36.03M to 60.53M, an increase of 67.98%. That is a compound annual growth rate of 4.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 7, 2026 | 60.53M | 147.95% |
| Dec 31, 2025 | 24.41M | 59.96% |
| Dec 31, 2024 | 15.26M | -14.98% |
| Dec 27, 2023 | 17.95M | -40.09% |
| Dec 29, 2022 | 29.96M | -30.67% |
| Dec 31, 2021 | 43.22M | -32.39% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vaxart | 148.88M |
| HST Global | 99.00M |
| NDT Pharmaceuticals | 87.78M |
| BioStem Technologies | 64.88M |
| Vicapsys Life Sciences | 47.26M |
| Nuo Therapeutics | 44.54M |
| ProText Mobility | 42.55M |
| Arch Biopartners | 41.30M |